NCT06744816View on ClinicalTrials.gov

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 5, 2026

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Peripheral Neuropathy Due to Chemotherapy

Interventions

DRUG

Qutenza Patch

Given topical

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Averitas Pharma, Inc.

All Listed Sponsors

collaborator

Averitas Pharma, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT06744816 - Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study | Biotech Hunter | Biotech Hunter